AGM/EGMSep 8, 2026, 07:01 AM
NovaBridge Biosciences Shareholders Remove Director Xin Liu at AGM
AI Summary
NovaBridge Biosciences convened its annual general meeting (AGM) on September 8, 2026. A quorum was established with approximately 44.8% of the company's outstanding shares represented. The primary outcome of the meeting was the shareholder approval, by ordinary resolution, to remove Ms. Xin Liu from her position as a director, effective immediately. The voting results indicated strong support for the removal.
Key Highlights
- NovaBridge Biosciences held its annual general meeting of shareholders on September 8, 2026.
- Approximately 44.8% of outstanding shares were represented at the AGM.
- Shareholders approved the removal of Ms. Xin Liu as a director with immediate effect.
- The resolution to remove Ms. Xin Liu passed with 107,925,508 votes in favor.
Price Impact
More from NBP